Inventiva (IVA) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Inventiva Revenue Highlights


Latest Revenue (Y)

$17.50M

Latest Revenue (Q)

$15.58M

Main Geography (Y)

JAPAN

Inventiva Revenue by Period


Inventiva Revenue by Year

DateRevenueChange
2023-12-31$17.50M43.69%
2022-12-31$12.18M190.39%
2021-12-31$4.19M1027.42%
2020-12-31$372.00K-94.68%
2019-12-31$7.00M118.89%
2018-12-31$3.20M-50.97%
2017-12-31$6.52M-30.96%
2016-12-31$9.45M93.77%
2015-12-31$4.87M48.49%
2014-12-31$3.28M7.13%
2013-12-31$3.06M-

Inventiva generated $17.50M in revenue during NA 2023, up 43.69% compared to the previous quarter, and up 547.39% compared to the same period a year ago.

Inventiva Revenue by Quarter

DateRevenueChange
2023-12-31$15.58M719.36%
2023-06-30$1.90M-84.30%
2022-12-31$12.11M17977.61%
2022-06-30$67.00K-98.35%
2021-12-31$4.05M6138.46%
2021-06-30$65.00K-12.16%
2021-03-31$74.00K-64.93%
2020-12-31$211.00K185.14%
2020-06-30$74.00K-14.94%
2020-03-31$87.00K-98.46%
2019-12-31$5.67M324.98%
2019-06-30$1.33M-23.81%
2019-03-31$1.75M-45.70%
2018-12-31$3.22M-22.49%
2018-06-30$4.16M420.11%
2018-03-31$799.25K-84.77%
2017-06-30$5.25M221.83%
2017-03-31$1.63M-65.35%
2017-01-31$4.70M-30.16%
2016-06-30$6.74M185.26%
2016-03-31$2.36M-68.92%
2016-01-31$7.60M523.38%
2015-09-30$1.22M-66.75%
2015-06-30$3.66M200.73%
2015-03-31$1.22M-75.60%
2015-01-31$5.00M508.64%
2014-09-30$820.73K-
2014-06-30$820.73K-
2014-03-31$820.73K-
2014-01-31$820.73K7.13%
2013-09-30$766.13K-
2013-06-30$766.13K-
2013-03-31$766.13K-
2013-01-31$766.13K-

Inventiva generated $15.58M in revenue during Q4 2023, up 719.36% compared to the previous quarter, and up 23963.08% compared to the same period a year ago.

Inventiva Revenue Breakdown


Inventiva Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
China$4.61M$12.05M
France$118.00K$125.00K
JAPAN$12.75M-

Inventiva's latest annual revenue breakdown by geography, as of Dec 23: JAPAN (72.95%), China (26.38%), and France (0.68%).

Inventiva Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
IMCRImmunocore$249.43M$75.40M
ACLXArcellx$110.32M$27.38M
IPHAInnate Pharma$51.90M$16.56M
IVAInventiva$17.50M$15.58M
NAMSNewAmsterdam Pharma Company$14.09M$1.40M
JANXJanux Therapeutics$8.08M$1.25M
VRCAVerrica Pharmaceuticals$5.12M$3.83M
HCWBHCW Biologics$2.84M$618.85K
INBXInhibrx Biosciences$1.80M-
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
CGEMCullinan Oncology--
LIANLianBio--
PCVXVaxcyte--
DICEDICE Therapeutics--
ELYMEliem Therapeutics--
VTYXVentyx Biosciences--
MLYSMineralys Therapeutics--
VIGLVigil Neuroscience--
GLUEMonte Rosa Therapeutics-$4.70M
CMPXCompass Therapeutics--
EWTXEdgewise Therapeutics--

IVA Revenue FAQ


Inventiva's yearly revenue for 2023 was $17.5M, representing an increase of 43.69% compared to 2022. The company's yearly revenue for 2022 was $12.18M, representing an increase of 190.39% compared to 2021. IVA's yearly revenue for 2021 was $4.19M, representing an increase of 1027.42% compared to 2020.

Inventiva's quarterly revenue for Q4 2023 was $15.58M, a 719.36% increase from the previous quarter (Q2 2023), and a 284.12% increase year-over-year (Q4 2021). The company's quarterly revenue for Q2 2023 was $1.9M, a -84.30% decrease from the previous quarter (Q4 2022), and a 2824.62% increase year-over-year (Q2 2021). IVA's quarterly revenue for Q4 2022 was $12.11M, a 17977.61% increase from the previous quarter (Q2 2022), and a 16267.57% increase year-over-year (Q1 2021).

Inventiva's revenue growth rate for the last 3 years (2021-2023) was 317.26%, and for the last 5 years (2019-2023) was 150.07%.